Oritavancin is a lipoglycopeptide with broad-spectrum activity against Gram-positive pathogens, such as staphylococci, including methicillin resistant Staphylococcus aureus (MRSA), streptococci and enterococci.
ComASP® (Compact Antimicrobial Susceptibility Panel) Oritavancin is a 2-test panel containing the dried up antibiotic in 15 two-fold dilutions (0.001-16 μg/ml).
ComASP® Oritavancin is used to perform the broth microdilution (BMD) method for the antimicrobial susceptibility testing of Oritavancin as recommended by international standards (i.e. CLSI, EUCAST, ISO 20776-1:2006).
Choose among one of the following nine preset panels or request customized 32-well panel formats with over 100 antibiotics available:
- Colistin / Piperacillin-tazobactam
- Ceftolozane-tazobactam / Ceftazidime-avibactam
- Vancomycin / Teicoplanin